Marinus Pharmaceuticals Inc (STU:61Y)
€ 0.292 0.076 (35.19%) Market Cap: 19.67 Mil Enterprise Value: 32.91 Mil PE Ratio: 0 PB Ratio: 0 GF Score: 36/100

Marinus Pharmaceuticals Inc at Morgan Stanley Global Healthcare Conference (Virtual) Transcript

Sep 09, 2021 / 07:30PM GMT
Release Date Price: €10.2 (+0.99%)
Rahul Sood

This is Rahul Sood here from Morgan Stanley's Healthcare Investment Banking Group. Before we begin and do the introductions, I would like to just read the disclaimer here. For important disclosures, please see the Morgan Stanley Research Disclosure website at www.morganstanley.com/researchdisclosures. If you have any questions, please reach out to your Morgan Stanley sales representative.

And just one more housekeeping item before we begin here -- one more housekeeping here. If somebody can go on mute. One more housekeeping item is that you can download the slide deck in the Event Resources tab that's available to you.

So with that, it's my pleasure to introduce Scott Braunstein, CEO of Marinus Pharmaceuticals; and Steve Pfanstiel, who is the CFO of Marinus Pharmaceuticals. So Scott, welcome. Thank you for joining us, and let me turn it over to you.

Scott N. Braunstein
Marinus Pharmaceuticals, Inc. - CEO, President & Director

Thanks, Rahul.

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot